Start-up and scale-up technology commercialisation specialist and Founder at First Longevity.
Phil has over 25 years of C-level management, marketing and business development expertise in Europe and North America. His creative background has helped him shape unconventional strategies for commercial growth - garnering both awards and investor ROI.
Phil has wide experience of technology transfer and the commercialisation of innovations from both private and institutional sources and this led to his interest in Longevity and the founding of Longevity.Technology.
Visit website: https://www.longevity.technology/author/pnewmanpergali-com/
See also: First Longevity - Media and finance business focused on the growing longevity market opportunity.
Phil Newman is also referenced in the following:
Online conference gathering longevity experts and investors at one place hosted by Marc P. Bernegger and Dr. Tobias Reichmuth
Conference gathering longevity experts and investors at one place hosted by Marc P. Bernegger and Dr. Tobias Reichmuth
In person, in San Diego, CA. Organised by Coalition for Radical Life Extension.
Articles written by Phil Newman
Cambrian Biopharma raised $60 million in stealth mode
Longevity Technology - 09-Feb-2021
New York-based biotech company with unique approaches to treat age-related diseasesRead more...
Big investors join First Longevity funding round
Longevity Technology - 16-Oct-2020
Key investors raise funding to support longevity sectorRead more...
Elysium Health releases new studies on its Basis NR supplement
Longevity Technology - 24-Aug-2020
Demonstrates safety as a NAD+ precursor dietary supplement, and also within a drug clinical trialRead more...
Donor supercentenarian’s cells help unlock mysteries of super-longevity
Longevity Technology - 28-Feb-2020
Evidence of cellular age reversal demonstrated in this gateway researchRead more...
Method of Generating Induced Pluripotent Stem Cells
Longevity Technology - 10-Dec-2019
New reprogramming technology could provide an alternate source of material needed for therapiesRead more...